Chronic Daily Migraine, Episodic Migraine
Conditions
Keywords
fMRI scans, episodic migraine sufferers, chronic migraine sufferers, non migraine sufferers (controls)
Brief summary
This is a 2 visit research study for patients with or without a diagnosis of migraine. Participants will be administered informed consent, have a medical history taken and a physical examination performed, and complete 3 questionnaires at the first visit. The participants will have a functional MRI performed after completion of Visit 1. Study stipends will be given for each completed research visit. The purpose of this study is to potentially identify risk factors and/or biomarkers (which are differences in the brain structures)by comparing the brain MRI scans of migraine sufferers to brain scans of control persons to attempt to identify migraine progression using the functional MRI scans.
Detailed description
At Visit 1, patients in 3 diagnostic arms,(consisting of subjects with episodic migraine, chronic daily migraine or non-migraineurs/controls), of 11 subjects each, will be consented and then have a physical exam, medical history and current medication use documented. Each of these enrolled subjects will have a PRIME MD assessment administered, and will complete the MIDAS and ASC-12 questionnaires. At Visit 2 these same subjects will have an fMRI performed. Subjects will be greater than age 18, have the appropriate diagnoses, be able to be consented and not be pregnant or have an inability to have the fMRI performed (have implanted metal devices, have severe claustrophobia).
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* adult episodic, chronic or non-migraine sufferers able to consent
Exclusion criteria
* contraindication to MRI such as severe claustrophobia and implanted devices such as neurostimulators, pacemakers, aneurysm clips, etc * pregnancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| assess anatomical changes with emphasis in iron deposition in brainstem structures of migraineurs and controls | within a month after consent is obtained |
Secondary
| Measure | Time frame |
|---|---|
| correlate outcomes with headache surrogates (frequency, time since onset and age) | within one month after enrollment |
Countries
United States